Explore chapters and articles related to this topic
Methods and Equipment for Quality Control of Radiopharmaceuticals
Published in Michael Ljungberg, Handbook of Nuclear Medicine and Molecular Imaging for Physicists, 2022
Rolf Zijlma, Danique Giesen, Yvette Kruiter, Philip H. Elsinga, Gert Luurtsema
FDG is produced by several pharmaceutical companies as well as at production sites in the academic world equipped with an onsite cyclotron and dedicated to good manufacturing production (GMP) facilities. After the production, FDG is sterilized and diluted in clinically practical doses. QC of the final product is performed, and if the product meets the criteria, it will be released by a qualified person (QP) for human intravenous administration [3].
Investigative Duties on Scene
Published in Kevin L. Erskine, Erica J. Armstrong, Water-Related Death Investigation, 2021
Care must be taken to ensure that all the diver’s equipment is recovered and preserved in the state in which it is found. Any alteration of the equipment must be avoided until a qualified person can examine it for defects or malfunctions. This will allow the investigator to determine if the equipment played a role in the death of the diver. Even items of seeming unimportance must be seized. This includes cameras, spear gun, flashlights, collection bag, etc. It is possible that some of these items may have contributed to the diver’s death by overloading him or her or requiring the diver to carry on multiple tasks. Immediate testing of the equipment should be done so that leaks, malfunctions, or mishandling does not prejudice the conclusions. A bulky item such as a large camera may have required multitasking the diver was not prepared for or may have caused overweighting of the diver, making it difficult to surface.
Introduction for Therapists
Published in Keren Fisher, Susan Childs, Lance McCracken, Glyn Towlerton, The Practical Pain Management Handbook, 2018
Keren Fisher, Susan Childs, Lance McCracken, Glyn Towlerton
Whether you choose to have inpatient or outpatient programmes depends on your resources. The British Pain Society reports that the degree of patients’ distress and disability may contribute more to treatment outcomes than whether or not the patients are residential. The core recommendation is that the staff should be specifically experienced and involve (in addition to a medically qualified person) a chartered clinical or health psychologist (or a suitably qualified cognitive behavioural therapist) and a chartered physiotherapist. The addition of a nurse and occupational therapist with specific competencies in chronic pain management is a great advantage.
Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan
Published in Current Medical Research and Opinion, 2022
Muhammad Junaid Hassan Sharif, Muhammad Junaid Farrukh, Faiz Ullah Khan, Qasim Khan, Sardar Shabbir Ahmed, Rozina Kousar, Tawseef Ahmad, Syed Mobasher Ali Abid, Muhammad Ashfaq, Shujaat Ali Khan
Several studies pointed out that almost 70–80% of doctors, pharmacists, and nurses considered all health care professionals to be qualified to report ADRs25,35,36 however, our study suggested contrasting results in which only 42.1% of participants considered all health care professionals equally important to report ADRs with similar findings from other studies as well29,37. Furthermore, only 33.9% of healthcare professionals agreed on pharmacists being the qualified person to deal with ADR reporting and monitoring. Contrasting results were seen in similar studies from Lahore where physicians and nurses emphasized that being more trained in medication safety, pharmacists should deal with ADR monitoring within the hospital32,38. These are interesting findings, and this difference of opinion might be because Punjab has a better infrastructure on pharmacovigilance and many pharmacists working in hospitals as compared to Khyber-Pakhtunkhwa which has very few hospitals pharmacists working in the government sector. It might also reflect a lack of acceptance of the role of all health care professionals toward each other in Khyber-Pakhtunkhwa.
Tramadol: a valuable treatment for pain in Ghana and Nigeria
Published in Current Medical Research and Opinion, 2019
Ernest Yorke, Folaju O. Oyebola, Samuel Anaja Otene, Axel Klein
When invited to speculate on the potential impact of “stronger regulations” the general response was that in the hospital environment there would be reduced access (almost certainly through a qualified person), greater adherence to guidelines and less importation of tramadol into the country. This would increase costs and decrease availability to patients needing the drug for pain relief. In the outpatient setting, stronger regulations would likely limit access, particularly in remote regions, drive up prices and would also increase demands on illegal supply. Ultimately, this would almost certainly result in poorer pain management in hospitals, in both the inpatient and outpatient settings, denying access to those most in need.
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?
Published in Expert Opinion on Drug Safety, 2018
Maurizio Sessa, Concetta Rafaniello, Cristina Scavone, Annamaria Mascolo, Gabriella di Mauro, Annamaria Fucile, Francesco Rossi, Liberata Sportiello, Annalisa Capuano
ICSRs having statins alone or in combination as suspected drugs were selected among those reported through the spontaneous reporting system from 1 July 2012 to 30 June 2017. ICSRs were retrieved from the Italian National database for Pharmacovigilance (Rete Nazionale di Farmacovigilanza, RNF). This database contains all ICSRs reported spontaneously, but also those deriving from active pharmacovigilance projects and observational studies. All ICSRs are entered in the RNF by the Qualified Person for Pharmacovigilance (QPPV) identified in a health structure after receiving them from a reporter. We utilized only ICSRs reported from Campania region.